Inoviv · 2 days ago
(Senior) Business Development Manager
Wonder how qualified you are to the job?
BiopharmaBiotechnology
Insider Connection @Inoviv
Responsibilities
Diagnose pharmaceutical companies’ scientific and business needs, present appropriate solutions and create customised proposals
Lead discussions related to mass spectrometry-based proteomics, neurodegenerative diseases, Fibrosis, COVID-19, and the benefits of our platform to deliver diagnostic, prognostic or treatment efficacy biomarkers for clinical trials
Evangelise the technology and company with the broader scientific community, including at conferences, with key opinion leaders and scientific groups
Pursue business opportunities with pharmaceutical companies, managing all aspects of the sales cycle from lead generation to close
Design biomarker studies according to client needs
Research target companies in order to understand pain points
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
3+ Years in Life Science Sales with a demonstrated track record of success
Deep knowledge of the Boston/Cambridge biotechnology/pharma landscape
Bachelor’s Degree or higher in biochemistry/ molecular biology/ or similar
Working knowledge of mass spectrometry and its applications
Experience with complex stakeholder management
Strong presentation, communication and negotiating skills
A passion for generating new business
Commitment to the company’s mission
Preferred
Strong understanding of the pharmaceutical industry and the role of biomarkers in clinical trials
Working knowledge of proteomics/’omics and its applicability in the drug development space
Benefits
Employee share options
20 days holiday + public holidays
Flexible working hours & remote working
Regular check-ins and feedback sessions
External coaching support
Quarterly team away days
Equipment budget
Open and respectful culture
Company
Inoviv
Accelerating the world’s transition to precision medicine through application of omics technologies to drug development and healthcare.
Funding
Current Stage
Early StageTotal Funding
unknownKey Investors
Hoxton Ventures
2024-01-30Series Unknown· Undisclosed
2021-06-06Seed· Undisclosed
2019-01-01Seed· Undisclosed
Recent News
Company data provided by crunchbase